Literature DB >> 10082039

Parotid region lymphatic mapping and sentinel lymphadenectomy for cutaneous melanoma.

D W Ollila1, L J Foshag, R Essner, S L Stern, D L Morton.   

Abstract

BACKGROUND: Routine elective superficial parotidectomy for patients with primary cutaneous melanomas of the scalp, auricle, or face has been questioned. We evaluated an alternative, i.e., lymphatic mapping and sentinel lymphadenectomy, for patients with primary cutaneous melanomas draining to the region of the parotid gland. PATIENTS: Retrospective review of our large (>8000 patients) melanoma database identified 39 patients with primary melanomas (American Joint Committee on Cancer stage I or II) of the scalp (n = 19), auricle (n = 11), or face (n = 9) who underwent intraoperative lymphatic mapping to identify a sentinel node (SN) in the region of the parotid gland, between June 1985 and July 1997.
RESULTS: A SN was identified in the parotid region of 37 patients (94.9%), four of whom had SN metastases. The mean number of SN obtained was 2.3/patient (range, 1-4/patient). The two patients (5.1%) for whom a parotid-region SN could not be identified underwent superficial parotidectomy during the same operation. Among the 33 patients with tumor-free SN, with a median follow-up period of 33.2 months (range, 1-121 months), there was one (3.1%) intraparotid recurrence; thus, the false-negative rate was 3.1%. The procedure-related surgical morbidity rate was only 2.6% (one case of temporary facial nerve paresis).
CONCLUSIONS: For patients with primary melanomas of the scalp, auricle, or face, sentinel lymphadenectomy can be performed accurately in the parotid region and offers a low-morbidity alternative to routine elective superficial parotidectomy.

Entities:  

Mesh:

Year:  1999        PMID: 10082039     DOI: 10.1007/s10434-999-0150-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  8 in total

1.  Tumor location predicts survival in cutaneous head and neck melanoma.

Authors:  Warren H Tseng; Steve R Martinez
Journal:  J Surg Res       Date:  2010-11-10       Impact factor: 2.192

2.  A false-negative sentinel lymph node in the parotid gland of a melanoma patient: a new algorithm for SLN biopsy in the parotid gland.

Authors:  Toshihiko Hayashi; Hiroshi Furukawa; Arata Tsutsumida; Tetsunori Yoshida
Journal:  Int J Clin Oncol       Date:  2010-03-16       Impact factor: 3.402

3.  Sentinel Lymph Node Biopsy for Cutaneous Head and Neck Melanoma: Mapping the Parotid Gland.

Authors:  Antonio I Picon; Daniel G Coit; Ashok R Shaha; Mary S Brady; Jay O Boyle; Bhuvanesh B Singh; Richard J Wong; Klaus J Busam; Jatin P Shah; Dennis H Kraus
Journal:  Ann Surg Oncol       Date:  2006-05-23       Impact factor: 5.344

4.  Head & neck melanoma: A 22-year experience of recurrence following sentinel lymph node biopsy.

Authors:  Kristen A Echanique; Shabnam Ghazizadeh; Andy Moon; Kera Kwan; Peter A Pellionisz; Dennis Rünger; David Elashoff; Maie St John
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-06-21

5.  [Surgical therapy of malignant melanoma of the external ear].

Authors:  P Dost; G Lehnerdt; R Kling; S N Wagner
Journal:  HNO       Date:  2003-06-19       Impact factor: 1.284

6.  Correlation between preoperative lymphoscintigraphy and metastatic nodal disease sites in 362 patients with cutaneous melanomas of the head and neck.

Authors:  Johannes H W de Wilt; John F Thompson; Roger F Uren; Vivian S K Ka; Richard A Scolyer; William H McCarthy; Christopher J O'Brien; Michael J Quinn; Kerwin F Shannon
Journal:  Ann Surg       Date:  2004-04       Impact factor: 12.969

7.  Lymphoscintigraphy defines new lymphatic pathways from cutaneous melanoma site: clinical implications and surgical management.

Authors:  Ugo Marone; Luigi Aloj; Gianluca Di Monta; Corrado Caracò
Journal:  Radiol Res Pract       Date:  2011-12-25

8.  Advantages of Sentinel Lymph Node Mapping by Single Photon Emission Computed Tomography/Computed Tomography in Early-Stage Malignant Head-and-Neck Skin Tumors.

Authors:  Enrique Cadena-Pineros; Juliaìn Goìmez-Herrera; Melissa Mayo-Patiño; Alexander Carreño
Journal:  Indian J Nucl Med       Date:  2022-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.